Lawrence Biegelsen analyst WELLS FARGO

Currently out of the existing stock ratings of Lawrence Biegelsen, 70 are a BUY (52.63%), 49 are a HOLD (36.84%), 14 are a SELL (10.53%).

Lawrence Biegelsen

Work Performance Price Targets & Ratings Chart

Analyst Lawrence Biegelsen, currently employed at WELLS FARGO, carries an average stock price target met ratio of 71.68% that have a potential upside of 12.73% achieved within 157 days.

Lawrence Biegelsen’s has documented 677 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TNDM, Tandem Diabetes Care at 03-May-2024.

Wall Street Analyst Lawrence Biegelsen

Analyst best performing recommendations are on NARI (INARI MEDICAL ).
The best stock recommendation documented was for NARI (INARI MEDICAL ) at 3/10/2021. The price target of $125 was fulfilled within 1 day with a profit of $6.73 (5.69%) receiving and performance score of 56.9.

Average potential price target upside

ALC Alcon AG BDX Becton Dickinson and Company BSX Boston Scientific Corp DXCM DexCom EAR Eargo  GKOS Glaukos Corp GMED Globus Medical ISRG Intuitive Surgical LUNG Pulmonx Corp MMSI Merit Medical Systems NPCE Neuropace NVRO Nevro Corp SWAV Shockwave Medical TFX Teleflex orporated TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings NUVA NuVasive PODD Insulet

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

101

$9.26 (10.09%)

101

2 days ago

8/16 (50%)

$9.26 (10.09%)

240

Buy

104

$12.26 (13.36%)

94

1 months 29 days ago

5/8 (62.5%)

$14.03 (15.59%)

284

Buy

105

$13.26 (14.45%)

100

1 months 29 days ago

8/12 (66.67%)

$15.03 (16.71%)

216

Buy

100

$8.26 (9.00%)

90

4 months 10 days ago

4/6 (66.67%)

$13.26 (15.29%)

311

Buy

85.28

$-6.46 (-7.04%)

87.39

7 months 23 days ago

3/3 (100%)

$12.94 (17.89%)

289

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Lawrence Biegelsen is most bullish on?

Potential upside of $8.56 has been obtained for NPCE (NEUROPACE)

Which stock is Lawrence Biegelsen is most reserved on?

Potential downside of -$5667.94 has been obtained for SWAV (SHOCKWAVE MEDICAL)

What Year was the first public recommendation made by Lawrence Biegelsen?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?